SOCS3 itself is involved in regulating pro-inflammatory cytokine signalling, and its expression has been found to be upregulated in the brains of patients with Alzheimer’s disease, suggesting it may be an important site in linking peripheral metabolic and inflammatory processes with central pathology and function [55]. The gene discussed is SOCS3; the disease is early-onset autosomal dominant Alzheimer disease.